Tech Company Financing Transactions
Cimeio Therapeutics Funding Round
On 4/13/2022, Cimeio Therapeutics announced Series A funding from Versant Ventures.
Transaction Overview
Company Name
Announced On
4/13/2022
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Versant Ventures (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Aeschenvorstadt 36
Basel, 4051
Switzerland
Basel, 4051
Switzerland
Phone
Website
Email Address
Not Recorded
Overview
We are an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs� for patients with debilitating and life-threatening diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Tristan Imbert
Chief Medical Officer
Thomas Winkler
Founder
Lukas Jeker
Browse more venture capital transactions:
Prev: 4/13/2022: Salsify venture capital transaction
Next: 4/13/2022: ITILITE venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs